Carrier protein having an adjuvant effect
AssigneePierre Fabre Medicament
InventorsHans Binz, Thierry Baussant, Jean-François Haeuw, Thien Ngoc Nguyen
Life of this patent
Estimating the term…
Loading patent…
AssigneePierre Fabre Medicament
InventorsHans Binz, Thierry Baussant, Jean-François Haeuw, Thien Ngoc Nguyen
Estimating the term…
The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protein of Klebsiella pneumoniae. The invention also relates to nucleotide sequences which encode these peptides or proteins and to the use of these sequences as a medicament. More particularly, such DNA sequences can be used in compositions which are intended for immunization by the intramuscular or intradermal route.
A process of increasing the immunogenicity of an antigen or a hapten comprising attaching the antigen or the hapten to an isolated adjuvant to form an immunogenic complex, wherein said adjuvant comprises the amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.